|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500102785 |
|
最近更新日期: Date of Last Refreshed on: |
2025-05-20 09:53:16 |
|
注册时间: Date of Registration: |
2025-05-20 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
ICU危重患者肠内喂养不耐受风险因素研究 |
|
Public title: |
Study on the Risk Factors for Intestinal Feeding Intolerance in Critically Ill ICU Patients |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
ICU危重患者肠内喂养不耐受风险因素研究 |
|
Scientific title: |
Study on the Risk Factors for Intestinal Feeding Intolerance in Critically Ill ICU Patients |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
曹晓花 |
研究负责人: |
曹晓花 |
|
Applicant: |
Cao Xiaohua |
Study leader: |
Cao Xiaohua |
|
申请注册联系人电话: Applicant telephone: |
+86 186 5378 0208 |
研究负责人电话:
Study leader's |
+86 186 5378 0208 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
zzyx8208@163.com |
研究负责人电子邮件: Study leader's E-mail: |
zzyx8208@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
济宁市任城区健康路6号 |
研究负责人通讯地址: |
济宁市任城区健康路6号 |
|
Applicant address: |
No. 6, Health Road, Rencheng District, Jining City |
Study leader's address: |
No. 6, Health Road, Rencheng District, Jining City |
|
申请注册联系人邮政编码: Applicant postcode: |
271000 |
研究负责人邮政编码: Study leader's postcode: |
271000 |
|
申请人所在单位: |
济宁市第一人民医院 |
||
|
Applicant's institution: |
Jining First People's Hospital |
||
|
研究负责人所在单位: |
济宁市第一人民医院 |
||
|
Affiliation of the Leader: |
Jining First People's Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
JNRM-2025-KY-013 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
济宁市第一人民医院科研伦理委员会 |
||
|
Name of the ethic committee: |
Jining First People's Hospital Research Ethics Committee |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-02-10 00:00:00 | ||
|
伦理委员会联系人: |
武雯程 |
||
|
Contact Name of the ethic committee: |
Wu Wencheng |
||
|
伦理委员会联系地址: |
济宁市任城区健康路6号 |
||
|
Contact Address of the ethic committee: |
No. 6, Health Road, Rencheng District, Jining City |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 186 5378 9831 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
zzyx8208@163.com |
|
研究实施负责(组长)单位: |
济宁市第一人民医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Jining First People's Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
济宁市任城区健康路6号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 6, Health Road, Rencheng District, Jining City |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自筹 |
||||||||||||||||||||||
|
Source(s) of funding: |
Self-raised |
||||||||||||||||||||||
|
研究疾病: |
危重患者肠内喂养不耐受 |
||||||||||||||||||||||
|
Target disease: |
Intestinal feeding intolerance in critically ill patients |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
连续入组 |
||||||||||||||||||||||
|
Study design: |
Sequential |
||||||||||||||||||||||
|
研究目的: |
研究目的 1.通过回顾性研究方法,分析ICU危重患者肠内喂养不耐受发生的关键影响因素,构建ICU危重患者肠内喂养不耐受风险预警模型,并比较是否引入腹内压变量对于预测模型的改善度,为ICU危重症患者开展肠内营养支持治疗的临床护理路径建设提供意见参考; 2.通过回顾性研究方法,分析ICU危重患者腹内压水平与胃残余量之间的相关性,为ICU临床进一步规范化开展肠内营养支持治疗提供理论支持; 3.通过回顾性研究方法,分析ICU危重患者腹内压水平与肠内喂养不耐受发生的相关性,为ICU临床进一步规范化开展肠内营养支持治疗提供理论支持。 |
||||||||||||||||||||||
|
Objectives of Study: |
Objectives: 1. Through retrospective research methods, the key influencing factors of enteral feeding intolerance in critically ill patients in ICU were analyzed, an early warning model for enteral feeding intolerance risk in critically ill patients in ICU was constructed, and the improvement of the prediction model was compared with whether intra-abdominal pressure variables were introduced, so as to provide opinions and references for the construction of clinical nursing pathways for critically ill patients in ICU to carry out enteral nutrition support treatment. 2. To analyze the correlation between the level of intra-abdominal pressure and the residual gastric volume in critically ill patients in ICU through retrospective research methods, so as to provide theoretical support for further standardization of enteral nutrition support therapy in ICU clinics; 3. To analyze the correlation between the level of intra-abdominal pressure and the occurrence of enteral feeding intolerance in critically ill patients in ICU through retrospective research methods, so as to provide theoretical support for further standardization of enteral nutrition support therapy in ICU clinics. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
存在营养风险且具有肠内营养治疗指征的危重症患者,根据NRS-2002或者NUTRIC评估表认为存在营养风险的患者(NRS-2002评估表>=3分或NUTRIC评估表>=6分或改良版NUTRIC评估表>=5分),入ICU 24h内采用APACHEⅡ评分系统得分位于15~30分的患者。 |
||||||||||||||||||||||
|
Inclusion criteria |
Critically ill patients with nutritional risk and indication for enteral nutrition therapy, patients who are considered to be at nutritional risk according to NRS-2002 or NUTRIC assessment form (NRS-2002 assessment form >=3 points or NUTRIC assessment form >=6 points or modified NUTRIC assessment form >=5 points), patients with APACHEII. scoring system score of 15~30 points within 24 hours of admission to the ICU. |
||||||||||||||||||||||
|
排除标准: |
不存在营养风险、无法进行肠内营养治疗、或者病情极危重的患者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
Patients who are not at nutritional risk, cannot be treated with enteral nutrition, or are critically ill. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-05-20 00:00:00至 To 2025-07-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2025-05-20 00:00:00 至 To 2025-07-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
无 |
|
Blinding: |
None |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
None |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
CRF |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
CRF |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |